Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Geou‐Yarh Liou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-2728-3752; OpenAlex author ID A5019543378; NIH RePORTER profile ID 14997420. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 1)
Trials
0
Grants
1
Labs led
0
Collaborators
16
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 1 grant · 2025: none · 2026: 1 paper

Papers 9

  1. Catching pancreatic cancer early: the promise of affordable biomarkers to regularly screen high-risk individuals. Co-author DOI 10.21037/tgh-2026-0064↗
  2. Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need. Co-author DOI 10.3390/cancers15092446↗
  3. Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer. Co-author DOI 10.1016/j.isci.2022.104327↗
  4. Oncogenic Kras-Mediated Cytokine CCL15 Regulates Pancreatic Cancer Cell Migration and Invasion through ROS. Last author DOI 10.3390/cancers14092153↗
  5. A bright future for protein kinase D1 as a drug target to prevent or treat pancreatic cancer. Co-author DOI 10.1080/23723556.2015.1035477↗
  6. NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation. Co-author DOI 10.1155/2016/5272498↗
  7. Protein kinase D enzymes: novel kinase targets in pancreatic cancer. Co-author DOI 10.1586/17474124.2015.1069706↗
  8. Inflammatory macrophages in pancreatic acinar cell metaplasia and initiation of pancreatic cancer. Co-author DOI 10.18632/oncoscience.151↗
  9. Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity. First author DOI 10.1371/journal.pone.0053676↗

Grants 1

  1. Dissecting mechanisms of tumor initiation via immunomodulation SC1GM140907↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peter Störz · 6 shared papers, 2013–2022 · strength 0.62
  2. Crystal J. Byrd · 1 shared paper, 2023 · strength 0.39
  3. Heike R. Döppler · 2 shared papers, 2013–2022 · strength 0.25
  4. Daniel D. Billadeau · 2 shared papers, 2016–2022 · strength 0.23
  5. Ligia I. Bastea · 1 shared paper, 2022 · strength 0.19
  6. Alicia K. Fleming Martinez · 1 shared paper, 2022 · strength 0.19
  7. William G. Hawkins · 1 shared paper, 2022 · strength 0.17
  8. Justin K. Messex · 1 shared paper, 2022 · strength 0.17
  9. Nabeel M. Bardeesy · 1 shared paper, 2022 · strength 0.17
  10. David G DeNardo · 1 shared paper, 2022 · strength 0.17
  11. Michael Leitges · 1 shared paper, 2016 · strength 0.10
  12. Marie C. Hasselluhn · 1 shared paper, 2016 · strength 0.06
  13. Jin‐San Zhang · 1 shared paper, 2016 · strength 0.06
  14. Elisabeth Heßmann · 1 shared paper, 2016 · strength 0.06
  15. Alexander Otto König · 1 shared paper, 2016 · strength 0.06
  16. Volker Ellenrieder · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.